These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 12655920)

  • 21. Effect of gamma-hydroxybutyrate on pain, fatigue, and alpha sleep anomaly in patients with fibromyalgia.
    Russell AS
    J Rheumatol; 1999 Dec; 26(12):2712. PubMed ID: 10606392
    [No Abstract]   [Full Text] [Related]  

  • 22. Comment on "The abrupt cessation of therapeutically administered sodium oxybate (GHB) may cause withdrawal symptoms".
    Zvosec DL; Smith SW
    J Toxicol Clin Toxicol; 2004; 42(1):121-3; author reply 125-7. PubMed ID: 15083950
    [No Abstract]   [Full Text] [Related]  

  • 23. [Life threatening symptoms of withdrawal of gamma-hydroxybutyrate].
    Veerman SR; Dijkstra HN; Liefting-Kluft I
    Tijdschr Psychiatr; 2010; 52(6):411-6. PubMed ID: 20544599
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Gamma-hydroxy butyrate withdrawal delirium: a case report.
    Miglani JS; Kim KY; Chahil R
    Gen Hosp Psychiatry; 2000; 22(3):213-5. PubMed ID: 11012302
    [No Abstract]   [Full Text] [Related]  

  • 25. Gamma-hydroxybutyrate serum levels and clinical syndrome after severe overdose.
    Sporer KA; Chin RL; Dyer JE; Lamb R
    Ann Emerg Med; 2003 Jul; 42(1):3-8. PubMed ID: 12827115
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Sodium oxybate: not authorised for fibromyalgia.
    Prescrire Int; 2012 Dec; 21(133):290. PubMed ID: 23373093
    [No Abstract]   [Full Text] [Related]  

  • 27. Prescribing sodium oxybate for narcolepsy.
    Zeman A; Zaiwalla Z
    BMJ; 2016 Apr; 353():i2367. PubMed ID: 27126864
    [No Abstract]   [Full Text] [Related]  

  • 28. Xyrem (sodium oxybate) postmarketing adverse event reporting system.
    Wang YG
    Sleep Med; 2010 Jun; 11(6):595; author reply 595-6. PubMed ID: 20362501
    [No Abstract]   [Full Text] [Related]  

  • 29. Rapid occurrence of depression following addition of sodium oxybate to modafinil.
    Rossetti AO; Heinzer RC; Tafti M; Buclin T
    Sleep Med; 2010 May; 11(5):500-1. PubMed ID: 20133191
    [No Abstract]   [Full Text] [Related]  

  • 30. Management of gamma-hydroxybutyrate withdrawal.
    Sharma AN; Lombardi MH; Illuzzi FA; Nelson LS
    Ann Emerg Med; 2001 Nov; 38(5):605-7. PubMed ID: 11679881
    [No Abstract]   [Full Text] [Related]  

  • 31. Two cases of withdrawal from 1,4-Butanediol use.
    Mycyk MB; Wilemon C; Aks SE
    Ann Emerg Med; 2001 Sep; 38(3):345-6. PubMed ID: 11524661
    [No Abstract]   [Full Text] [Related]  

  • 32. Sodium oxybate for the treatment of fibromyalgia.
    Staud R
    Expert Opin Pharmacother; 2011 Aug; 12(11):1789-98. PubMed ID: 21679091
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Lack of efficacy of benzodiazepines in treating gamma-hydroxybutyrate withdrawal.
    Mullins ME; Fitzmaurice SC
    J Emerg Med; 2001 May; 20(4):418-20. PubMed ID: 11396429
    [No Abstract]   [Full Text] [Related]  

  • 34. Epileptic seizure in GHB withdrawal.
    Chew G; Fernando A
    Australas Psychiatry; 2004 Dec; 12(4):410-1. PubMed ID: 15715821
    [No Abstract]   [Full Text] [Related]  

  • 35. Sodium oxybate is an effective and safe treatment for narcolepsy.
    Lammers GJ; Bassetti C; Billiard M; Black J; Broughton R; Dauvilliers Y; Ferini Strambi L; Garcia-Borreguero D; Goswami M; Högl B; Iranzo A; Jennum P; Khatami R; Lecendreux M; Mayer G; Mignot E; Montplaisir J; Nevsimalova S; Peraita-Adrados R; Plazzi G; Scammell T; Silber M; Sonka K; Tafti M; Thorpy M
    Sleep Med; 2010 Jan; 11(1):105-6; author reply 106-8. PubMed ID: 19846338
    [No Abstract]   [Full Text] [Related]  

  • 36. Gamma-hydroxybutyrate withdrawal syndrome.
    Dyer JE; Roth B; Hyma BA
    Ann Emerg Med; 2001 Feb; 37(2):147-53. PubMed ID: 11174231
    [TBL] [Abstract][Full Text] [Related]  

  • 37. GHB-induced delirium: a case report and review of the literature of gamma hydroxybutyric acid.
    Hernandez M; McDaniel CH; Costanza CD; Hernandez OJ
    Am J Drug Alcohol Abuse; 1998 Feb; 24(1):179-83. PubMed ID: 9513637
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Gamma-hydroxybutyric acid (GHB) withdrawal: a case report.
    Bennett WR; Wilson LG; Roy-Byrne PP
    J Psychoactive Drugs; 2007 Sep; 39(3):293-6. PubMed ID: 18159783
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [GHB withdrawal delirium].
    Stijnenbosch PJ; Zuketto C; Beijaert PJ; Maat A
    Ned Tijdschr Geneeskd; 2010; 154():A1086. PubMed ID: 20132572
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The assessment and management of gamma hydroxybutyrate use in general practice.
    Phan V; Arunogiri S; Lubman DI
    Aust J Gen Pract; 2020; 49(1-2):73-78. PubMed ID: 32008260
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.